E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/9/2008 in the Prospect News Special Situations Daily.

Obrem Capital owns 5.1% of MDS

By Lisa Kerner

Charlotte, N.C., April 9 - Obrem Capital Management, LLC and its affiliates reported beneficial ownership of 6,242,200 shares, or 5.1%, of MDS Inc. in a schedule 13D filing with the Securities and Exchange Commission.

The shares were acquired between Feb. 22 and April 8 priced from $16.19 to $20.60 each.

MDS is a life sciences company based in Toronto.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.